News

EXPAREL was approved in 2011 for administration into the surgical site to produce postsurgical analgesia. The complaint outlines the Company’s belief that the FDA has violated the Administrative

The proprietary technology was originally developed by a team headed by Prof. Ehud Gazit of the George S. Wise Faculty of Life Sciences at Tel Aviv University. The

The data being presented today at the World Conference on Lung Cancer (WCLC) 2015 were from the AURA Phase I trial first-line cohort and two AURA Phase II

As per the deal, the university will identify drug candidates in a co-funded laboratory led by its professor Shudong Wang. Yabao Pharmaceuticals will offer cash and in-kind towards

The new products include an Adrafinil supplement, Liposomal Vitamin C, a Noopept supplement and various others. The company said the Adrafinil supplement helps people in maintaining their mental

The move is part of a second reassessment of the CDF. Two myeloma drugs Imnovid (pomalidomide) and Revlimid, will no longer be funded on the NHS in England.

It can be used to treat patients with multiple myeloma who are refractory to both a proteasome inhibitor (PI) and an immunomodulatory agent (IMiD), or who have received

Genentech, a member of the Roche Group, said hemophilia A occurs when a blood clotting protein called factor VIII is either not present in required amounts or is

Farydak is used for the treatment of adult patients with relapsed and/or refractory multiple myeloma who have received at least two prior regimens including bortezomib and an immunomodulatory